arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MYOMO, INC.

MYO
$1.19 ▼ -0.11 (-8.85%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
43 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

MYOMO, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $50.8M
Dividend Yield —
Revenue Growth 21.3% ↗
Op. Margin -19.3% ↗
ROIC -13.1% ↗
FCF / Share $-0.05 ↗
Trailing P/E —
Price / Book 8.1x
FCF Yield —
Debt / Equity 1.98
info Valuation on last close. End-of-day price, Nov 5, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.70M
↑ +21.3% —
Net Income Profit after all expenses
$-3.01M
↑ +13.2% —
Operating Margin Operating profit as % of sales
-19.3%
↑ +38.3% 7th
FCF / Share Free cash flow per share
$-0.05
↑ +22.5% —
Long-Term Debt Long-term obligations
$11.53M
↑ +5.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
6
Returns ↓
6
Financial Health →
21
Cash Quality ↑
68

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 43 quarters